Skip to main content
Equibles

Legal & General Group Plc

Position in PTCT — Ptc Therapeutics, Inc.

CIK 764068 London, X0
Back to PTCT Full portfolio

Position in PTCT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$28,772,512
+$5,378,034 QoQ
Shares Held
352,734
+2.7% QoQ
Ownership
0.423%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 383 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PTCT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Legal & General Group Plc holds $3,299,239,490 across 292 Biotechnology names. PTCT ranks #14 (0.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 1,870,015 $928,892,550
2 REGN
Regeneron Pharmaceuticals, Inc.
 759,971 $473,872,316
3 ALNY
Alnylam Pharmaceuticals, Inc.
 924,561 $278,320,596
4 RPRX
Royalty Pharma plc
 3,800,504 $213,094,258
5 INCY
Incyte Corp
 1,605,980 $182,053,892
6 ARGX
Argenx SE
 177,164 $164,367,443
7 INSM
INSMED Inc
 826,431 $88,114,072
8 RVMD
Revolution Medicines, Inc.
 381,366 $71,422,223

All Filings in PTCT

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,772,512 352,734
2026-03-31 $23,394,478 343,380
2025-12-31 $27,821,487 366,265
2025-09-30 $14,811,157 241,342
2025-06-30 $10,883,357 222,837
2025-03-31 $9,827,329 192,844
2024-12-31 $3,639,547 80,628
2024-09-30 $2,919,954 78,705
2024-06-30 $2,332,212 76,266
2024-03-31 $2,091,512 71,898
2023-12-31 $2,434,842 88,347
2023-09-30 $2,256,014 100,670
2023-06-30 $4,007,743 98,543
2023-03-31 $5,298,414 109,381
2022-12-31 $3,276,550 85,841
2022-09-30 $4,045,014 80,578
2022-06-30 $3,627,432 90,550
2022-03-31 $3,406,813 91,311
2021-12-31 $3,385,589 85,001
2021-09-30 $3,181,974 85,514
2021-06-30 $1,909,334 45,170
2021-03-31 $1,789,308 37,789
2020-12-31 $2,460,546 40,317
2020-09-30 $1,596,371 34,147
2020-06-30 $2,455,662 48,397
2020-03-31 $1,855,506 41,594